| P2093 | author name string | B A C Dijkmans | |
| | J W R Twisk | |
| | H W Reesink | |
| | I E van der Horst-Bruinsma | |
| | A E Voskuyl | |
| | M T Nurmohamed | |
| | V P van Halm | |
| | R J van de Stadt | |
| | D van Schaardenburg | |
| | M M J Nielen | |
| | M H M T de Koning | |
| | M R Habibuw | |
| P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| | Multilevel modelling of medical data | Q28206769 |
| | Inflammation in atherosclerosis | Q29547428 |
| | Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group | Q29619877 |
| | Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis | Q33563669 |
| | C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? | Q33678964 |
| | Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women | Q34067367 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | The mortality of rheumatoid arthritis | Q34338843 |
| | Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study | Q34647260 |
| | High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? | Q35172225 |
| | Mortality in rheumatoid arthritis patients with disease onset in the 1980s | Q35548197 |
| | Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis | Q35553035 |
| | Coronary risk factors predicting early and late coronary deaths | Q35580765 |
| | Inflammation and atherosclerosis: role of C-reactive protein in risk assessment | Q35721270 |
| | Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors | Q40532147 |
| | Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease | Q40753215 |
| | Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes | Q43567044 |
| | A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction | Q43603017 |
| | High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study | Q43832976 |
| | Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). | Q44063974 |
| | Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. | Q44123361 |
| | Forty-year mortality from cardiovascular diseases and all causes of death in the US Railroad cohort of the Seven Countries Study | Q44197742 |
| | Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease | Q44341495 |
| | Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study | Q44973310 |
| | Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. | Q50701881 |
| | Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. | Q55038939 |
| | Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins | Q69178177 |
| | Serum paraoxonase activity decreases in rheumatoid arthritis | Q73274822 |
| | Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset | Q73292550 |
| | Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis | Q74169414 |
| | High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 |
| | Lipid profiles in untreated patients with rheumatoid arthritis | Q78139431 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipid | Q11367 |
| | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 184-188 | |
| P577 | publication date | 2006-06-07 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis | |
| P478 | volume | 66 | |